Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

BABYLON PUMP & POWER LIMITED Capital/Financing Update 2017

May 11, 2017

64557_rns_2017-05-11_8ea2cdb7-f50f-4794-8182-503d991c5f56.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Appendix 3B New issue announcement

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New issue announcement, application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 1/7/96. Origin: Appendix 5. Amended 1/7/98, 1/9/99, 1/7/2000, 30/9/2001, 11/3/2002, 1/1/2003, 24/10/2005.

Name of entity

IM Medical Limited (“ Company ”)

ABN

47 009 436 908

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

1
+Class of+securities issued or to be
issued
2
Number of+securities issued or to be
issued (if known) or maximum number
which may be issued
3
Principal terms of the+securities (eg, if
options, exercise price and expiry date;
if partly paid+securities, the amount
outstanding and due dates for payment;
if+convertible securities, the conversion
price and dates for conversion)		 Fully paid ordinary shares and free attaching options.
498,237,396 fully paid ordinary shares.
498,237,396 free attaching options.
Fully paid ordinary shares
Free attaching options (each with an exercise price of
$0.002 expiring or before 31 March 2019)
  • See chapter 19 for defined terms.

Appendix 3B Page 1

10472797_1

Appendix 3B New issue announcement

4
Do the+securities rank equally in all
respects from the date of allotment with
an existing+class of quoted+securities?
If the additional securities do not rank
equally, please state:
• the date from which they do
• the extent to which they participate
for the next dividend, (in the case of
a trust, distribution) or interest
payment
• the extent to which they do not rank
equally, other than in relation to the
next dividend, distribution or interest
payment
5
Issue price or consideration
6
Purpose of the issue
(If issued as consideration for the
acquisition of assets, clearly identify
those assets)
7
Dates of entering+securities into
uncertificated holdings or despatch of
certificates
8
Number and+class of all+securities
quoted on ASX (_including_the
securities in clause 2 if applicable)		 Shares will rank equally with existing fully paid
ordinary shares.
Free attaching options will rank equally with
existing listed IMIOA options. Shares issued on
exercise of the options to shares will rank
equally with existing shares.		 Shares will rank equally with existing fully paid
ordinary shares.
Free attaching options will rank equally with
existing listed IMIOA options. Shares issued on
exercise of the options to shares will rank
equally with existing shares.
$0.001 cents per Share.
Options free attaching on the basis of one
option for every share subscribed for under the
offer.
Non-renounceable pro-rata offer to eligible
shareholders as at the record date. Funds
raised will be used for the payment of liabilities
and existing creditors and to provide working
capital.
12 May 2017
Number +Class
1,826,870,453
993,302,151		 Fully paid ordinary
shares.
Options exercisable at
$0.002 on or before
31 March 2019.
  • See chapter 19 for defined terms.

Appendix 3B Page 2

10472797_1

Appendix 3B New issue announcement

9
Number and+class of all+securities
not quoted on ASX (_including_the
securities in clause 2 if applicable)		 Number +Class

10 Dividend policy (in the case of a trust, distribution policy) on the increased No change. capital (interests)

Part 2 - Bonus issue or pro rata issue

11
Is security holder approval required?
12
Is the issue renounceable or non-
renounceable?
13
Ratio in which the+securities will be
offered
14
+Class of+securities to which the offer
relates
15
+Record date to determine entitlements		 No
non-renounceable
3 Shares for every 8 Shares held.
1 free attaching option for each new share
subscribed for under the offer.
Fully paid ordinary shares.
Free attaching options (each with an exercise
price of $0.002 expiring or before 31 March
2019).
10 April 2017
  • See chapter 19 for defined terms.

Appendix 3B Page 3

10472797_1

Appendix 3B New issue announcement

16
Will holdings on different registers (or
subregisters) be aggregated for
calculating entitlements?
17
Policy for deciding entitlements in
relation to fractions
18
Names of countries in which the entity
has+security holders who will not be
sent new issue documents
Note: Security holders must be told how
their entitlements are to be dealt with.
Cross reference: rule 7.7.
19
Closing date for receipt of acceptances
or renunciations
20
Names of any underwriters
21
Amount of any underwriting fee or
commission
22
Names of any brokers to the issue
23
Fee or commission payable to the
broker to the issue
24
Amount of any handling fee payable to
brokers who lodge acceptances or
renunciations on behalf of+security
holders
25
If the issue is contingent on+security
holders’ approval, the date of the
meeting
26
Date entitlement and acceptance form
and prospectus or Product Disclosure
Statement will be sent to persons
entitled
27
If the entity has issued options, and the
terms entitle option holders to
participate on exercise, the date on
which notices will be sent to option
holders
28
Date rights trading will begin (if
applicable)
29
Date rights trading will end (if		 Yes
Rounded down
All countries other than Australia and New
Zealand
5 May 2017
Patersons Securities Limited
6.50% on the total amount raised under the
offer
Patersons Securities Limited
Nil
Nil
N/A
13 April 2017
13 April 2017
N/A
N/A
  • See chapter 19 for defined terms.

Appendix 3B Page 4

10472797_1

Appendix 3B New issue announcement

applicable) 30 How do[+] security holders sell their N/A entitlements in full through a broker? 31 How do[+] security holders sell part of their entitlements through a broker and N/A accept for the balance? 32 How do[+] security holders dispose of their entitlements (except by sale N/A through a broker)? 33 +Issue date 12 May 2017

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities

34 Type of securities ( tick one ) (a)[Securities described in Part 1 ]

  • (b)[All other securities ]

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

Tick to indicate you are providing the information or documents

35 If the[+] securities are[+] equity securities, the names of the 20 largest holders of the additional +securities, and the number and percentage of additional +securities held by those holders

36 If the[+] securities are[+] equity securities, a distribution schedule of the additional[+] securities setting out the number of holders in the categories 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001 and over

37 A copy of any trust deed for the additional[+] securities

  • See chapter 19 for defined terms.

Appendix 3B Page 5

10472797_1

Appendix 3B New issue announcement

Entities that have ticked box 34(b)

38
Number of securities for which
+quotation is sought
39
Class of+securities for which quotation
is sought
40
Do the+securities rank equally in all
respects from the date of allotment with
an existing+class of quoted+securities?
If the additional securities do not rank
equally, please state:
• the date from which they do
• the extent to which they participate
for the next dividend, (in the case of
a trust, distribution) or interest
payment
• the extent to which they do not rank
equally, other than in relation to the
next dividend, distribution or interest
payment
41
Reason for request for quotation now
Example: In the case of restricted securities,
end of restriction period
(if issued upon conversion of another
security, clearly identify that other
security)
42
Number and+class of all+securities
quoted on ASX (_including_the securities
in clause 38)
Number +Class
  • See chapter 19 for defined terms.

Appendix 3B Page 6

10472797_1

Appendix 3B New issue announcement

Quotation agreement

  • 1 +Quotation of our additional +securities is in ASX’s absolute discretion. ASX may quote the[+] securities on any conditions it decides.

  • 2 We warrant the following to ASX.

  • The issue of the[+] securities to be quoted complies with the law and is not for an illegal purpose.

  • There is no reason why those[+] securities should not be granted[+] quotation.

  • An offer of the[+] securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

  • Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any[+] securities to be quoted and that noone has any right to return any[+] securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the[+] securities be quoted.

  • If we are a trust, we warrant that no person has the right to return the[+] securities to be quoted under section 1019B of the Corporations Act at the time that we request that the[+] securities be quoted.

  • 3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

  • 4 We give ASX the information and documents required by this form. If any information or document not available now, will give it to ASX before[+] quotation of the[+] securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

Sign here: ............................................................ (Director/Company secretary)

Date: 12 May 2017

Print name: Richard Wadley

== == == == ==

  • See chapter 19 for defined terms.

Appendix 3B Page 7

10472797_1

Previous Top
* As at: 12/05/17 *		 1
2
3
4
5
107
6
7
8
9
10
11
12
13
14
15
16
17
18
Rank
8.06%
4.04%
3.56%
3.52%
3.49%
0.13%
3.24%
3.12%
2.53%
2.53%
2.38%
2.21%
2.10%
1.97%
1.63%
1.60%
1.42%
1.42%
1.27%
50.22%
%
127,470,237
63,879,831
56,354,629
55,609,091
55,141,188
2,078,676
51,218,750
49,317,507
40,000,009
40,000,000
37,643,549
35,000,000
33,227,273
31,095,852
25,781,250
25,326,834
22,500,000
22,500,000
20,000,018
794,144,694
Prev. Securities
Current
Date - 12/05/2017 Time - 8.10.26		 10.73%
6.98%
3.50%
3.08%
3.04%
3.02%
2.85%
2.80%
2.70%
2.19%
2.19%
2.06%
1.92%
1.82%
1.70%
1.41%
1.39%
1.23%
1.23%
1.09%
56.93%
%
196,069,080
127,470,237
63,879,831
56,354,629
55,609,091
55,141,188
52,078,676
51,218,750
49,317,507
40,000,009
40,000,000
37,643,549
35,000,000
33,227,273
31,095,852
25,781,250
25,326,834
22,500,000
22,500,000
20,000,018
1,040,213,774
Current Securities
SUPER ACCOUNT
HM A/C
GNR SUPER FUND A/C
CORP FINANCE A/C
CELATO A/C
SUPER ACCOUNT
SPRINGDALE NO 2 A/
S GOULOPOULOS F/SU
MCGHEE S/F A/C
HOPSCOTCH S/F A/C
SUPER ACCOUNT
MG FAM A/C
RETZOS ALTONA PROP
TOP 20 TOTAL
Designation
CHESAPEAKE CAP LTD
BAHEN MARK JOHN + M P
BEIRNE TRADING PL
BROWN BRICKS PL
G & N LORD SUPER PL
PATERSONS SEC LTD
FERNLAND HLDGS PL
TWO TOPS PL
T T NICHOLLS PL
KIRZY PL
SKYE EQUITY PL
ALDERHAUS PL
SAM GOULOPOULOS PL
REDCLIFF PL
HOPPSCOTCH PL
KOBIA HLDGS PL
JASPER HILL RES PL
ATLANTIS MG PL
RETZOS INV PL
LOQUELA PL
Denotes merged holders.
Note: All holders are included in the report.
Holder Name*
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Rank




*

==> picture [47 x 124] intentionally omitted <==

==> picture [49 x 130] intentionally omitted <==

==> picture [161 x 52] intentionally omitted <==

==> picture [185 x 68] intentionally omitted <==

IM MEDICAL LTD FULLY PAID Spread Analysis Date - 12/05/2017 Time - 8.10.26

Spread of Holdings Holders Securities % of
Issued Capital
NIL holding 0 0 0.00%
1 - 1,000 2,615 885,633 0.05%
1,001 - 5,000 1,133 2,978,621 0.16%
5,001 - 10,000 354 2,830,633 0.15%
10,001 - 100,000 438 13,702,830 0.75%
Over 100,000 332 1,806,472,736 98.88%
TOTAL ON REGISTER 4,872 1,826,870,453
Analysis by Location
Overseas 98 26,594,660 1.46%
Australia: 4,184 1,794,332,032 98.22%
ACT 51 700,334 0.04%
NSW 961 149,716,775 8.20%
VIC 1,553 310,599,111 17.00%
QLD 521 47,613,704 2.61%
SA 366 17,990,985 0.98%
WA 625 1,264,491,741 69.22%
TAS 86 2,933,736 0.16%
NT 21 285,646 0.02%
Address Unknown 590 5,943,761 0.33%
TOTAL ON REGISTER 4,872 1,826,870,453

Note: All holders are included in the report, with common holders merged into one holding.

Previous Top
* As at: 12/05/17 *		 1
91
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
Rank
8.54%
0.08%
6.40%
5.76%
5.49%
4.30%
4.10%
4.00%
3.88%
3.00%
2.80%
2.64%
2.51%
2.37%
2.28%
2.25%
1.76%
1.71%
1.55%
65.42%
%
63,790,182
566,911
47,842,636
43,007,047
41,014,610
32,152,273
30,663,644
29,909,091
28,959,604
22,431,818
20,947,546
19,704,545
18,750,000
17,718,750
17,031,250
16,838,654
13,136,364
12,750,000
11,565,554
488,780,479
Prev. Securities
Current
Date - 12/05/2017 Time - 8.11.56		 19.74%
6.42%
5.09%
4.82%
4.33%
4.13%
3.24%
3.09%
3.01%
2.92%
2.26%
2.11%
1.98%
1.89%
1.78%
1.71%
1.70%
1.32%
1.28%
1.16%
73.98%
%
196,069,080
63,790,182
50,566,911
47,842,636
43,007,047
41,014,610
32,152,273
30,663,644
29,909,091
28,959,604
22,431,818
20,947,546
19,704,545
18,750,000
17,718,750
17,031,250
16,838,654
13,136,364
12,750,000
11,565,554
734,849,559
Current Securities
CELATO A/C
TROJAN CAP FUND A/
SUPER ACCOUNT
SUPER ACCOUNT
GNR SUPER FUND A/C
SPRINGDALE NO 2 A/
HM A/C
MCGHEE S/F A/C
XCELERATE TRADING
JANE KIDMAN A/C
HOPSCOTCH S/F A/C
TOP 20 TOTAL
Designation
CHESAPEAKE CAP LTD
BEIRNE TRADING PL
FERNLAND HLDGS PL
ROCKET SCIENCE PL
T T NICHOLLS PL
BAHEN MARK JOHN + M P
G & N LORD SUPER PL
KIRZY PL
BROWN BRICKS PL
ALDERHAUS PL
REDCLIFF PL
EVANS SIMON ROBERT
WALLCLIFFE COTTAGES PL
XCELERATE TRADING PL
TWO TOPS PL
KOBIA HLDGS PL
LOQUELA PL
HOWARD TRADING CO PL
KIDMAN JANE CHRISTABEL
HOPPSCOTCH PL
Denotes merged holders.
Note: All holders are included in the report.
Holder Name*
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Rank




*

==> picture [47 x 124] intentionally omitted <==

==> picture [49 x 130] intentionally omitted <==

==> picture [161 x 52] intentionally omitted <==

==> picture [185 x 68] intentionally omitted <==

IM MEDICAL LTD OPTIONS EXP 31/03/2019 @ $0.002 Spread Analysis Date - 12/05/2017 Time - 8.11.56

Spread of Holdings Holders Securities % of
Issued Capital
NIL holding 0 0 0.00%
1 - 1,000 19 17,030 0.00%
1,001 - 5,000 39 109,262 0.01%
5,001 - 10,000 14 107,744 0.01%
10,001 - 100,000 39 1,887,134 0.19%
Over 100,000 136 991,180,981 99.79%
TOTAL ON REGISTER 247 993,302,151
Analysis by Location
Overseas 3 9,684,190 0.97%
Australia: 244 983,617,961 99.03%
ACT 1 10,000 0.00%
NSW 50 94,538,214 9.52%
VIC 66 154,059,808 15.51%
QLD 33 61,561,125 6.20%
SA 17 8,489,764 0.85%
WA 71 664,610,996 66.91%
TAS 6 348,054 0.04%
NT 0 0 0.00%
Address Unknown 0 0 0.00%
TOTAL ON REGISTER 247 993,302,151

Note: All holders are included in the report, with common holders merged into one holding.

More from BABYLON PUMP & POWER LIMITED

M&A Activity 2026
May 18
Interim / Quarterly Report 2026
Apr 28
Regulatory Filings 2026
Apr 26
Regulatory Filings 2026
Apr 26
Regulatory Filings 2026
Apr 21
Regulatory Filings 2026
Apr 19
Interim / Quarterly Report 2026
Feb 25
Interim / Quarterly Report 2026
Feb 25
Director's Dealing 2026
Feb 10
Interim / Quarterly Report 2026
Jan 29
View all filings →